Industry Research Reports
Home > Reports > Service & Software > Global Protein Analysis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Protein Analysis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Service & Software
Published Date: 2026-07-30
Pages: 142 Pages
Report ld: 6983266
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
KEY FINDINGS
North America is the largest regional market while Europe has the densest specialist supplier ecosystem
Mapping media-server and automatic calibration solutions form the broadest product and supplier base
Industrial guidance and high-end immersive experiences are the principal value-added application areas
China is moving from project integration toward reusable software platforms and AI-enabled spatial mapping
Protein Analysis Services Market Size(US$)
CAGR 2026-2032
8.6%
Market Size,2032
USD 7,638
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 4,651 million
Market Forecast in 2032(Value)
US$ 7,638 million
CAGR
8.6%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Protein Analysis Services market size was US$ 4312 million in 2025 and is forecast to reach a readjusted size of US$ 7638 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Protein Analysis Services refer to outsourced laboratory, method-development, data-processing, and scientific-interpretation services that directly evaluate proteins or protein-related critical quality attributes. The market covers the analysis of purified proteins, antibodies, enzymes, recombinant proteins, biotherapeutic drug substances and products, and complex biological samples such as plasma, serum, cells, tissues, culture media, and extracellular vesicles. Major service forms include protein identification and quantification, peptide mapping and sequence confirmation, post-translational modification analysis, glycan and charge-variant profiling, purity and impurity testing, aggregation and higher-order structure characterization, protein interaction and binding studies, enzymatic and cell-based potency assays, and regulated large-molecule pharmacokinetic, immunogenicity, and biomarker analysis. Core technologies include liquid chromatography–mass spectrometry, capillary electrophoresis, chromatography, immunoassays, affinity-based high-plex proteomics, spectroscopy, light scattering, surface plasmon resonance, biolayer interferometry, and functional cell assays. These services support drug discovery, translational research, preclinical and clinical development, biologics CMC, biosimilar comparability, process optimization, lot release, stability assessment, and commercial lifecycle management.
MARKET TRENDS
Protein Analysis Services are shifting from isolated laboratory tests toward integrated, high-throughput, and multi-platform analytical programs. Mass-spectrometry workflows are adopting data-independent acquisition, deeper plasma-proteome coverage, improved post-translational modification analysis, and greater automation, while affinity-based platforms are enabling standardized measurement of large protein panels across extensive clinical cohorts. Customers increasingly expect laboratories to combine wet-laboratory testing with bioinformatics, pathway interpretation, quality documentation, and integration with genomic, transcriptomic, and clinical data. Industry consolidation is reinforcing this transition: Thermo Fisher Scientific completed its acquisition of Olink in 2024, Illumina completed its acquisition of SomaLogic in January 2026, and Bruker has integrated Biognosys through a majority-ownership investment. These transactions are bringing instruments, proprietary assays, software, consumables, and contract services into broader multiomics ecosystems. Nevertheless, affinity platforms and mass spectrometry are expected to remain complementary, with the former emphasizing high-throughput standardized profiling and the latter retaining advantages in unbiased discovery, sequence confirmation, structural analysis, and modification characterization.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific Inc.
- Eurofins Scientific SE
- Labcorp Holdings Inc.
- SGS SA
- Charles River Laboratories International, Inc.
- BioAgilytix Labs,LLC
- Merck KGaA
- WuXi AppTec Co., Ltd.
- Intertek Group plc
- Frontage Laboratories,Inc.
- KCAS Bioanalytical Services
- QPS HoIdings, LLC
- CellCarta Biosciences Inc.
- Solvias AG
- Bruker Corporation
- Precision for Medicine
- Illumina, Inc.
- Pharmaron Beijing Co.,Ltd.
- Evotec SE
- Syngene International Limited
- Novogene Co., Ltd.北京诺禾致源科技股份有限公司
- Aragen Life Sciences Limited
- ProtaGene GmbH
- BGI Genomics Co., Ltd.
- Hangzhou Jingjie Biotechnology Co., Ltd.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Regulated Bioanalysis and Protein Biomarker Quantification
- Discovery Proteomics and Proteome Profiling
- Structural and Physicochemical Characterization
- Others
Segment by Application
- Biopharmaceutical and Biotechnology Companies
- Pharmaceutical Companies
- Academic and Research Institutions
- Others
Segment by Category
- Mass Spectrometry-based Analysis
- Affinity and Immunoassay-based Analysis
- Chromatography and Electrophoresis
- Others
Segment by Division
- Discovery Research
- Preclinical and IND-enabling
- Clinical Development
- Others
MARKET DYNAMICS
Drivers
Market demand is supported by the expanding development of monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, recombinant proteins, vaccines, and other complex biological modalities. These products require extensive analysis of identity, purity, molecular heterogeneity, glycosylation, aggregation, process-related impurities, biological activity, and comparability throughout development and commercialization. Translational medicine and precision-drug programs are also increasing demand for protein biomarkers that can support target validation, patient stratification, pharmacodynamic monitoring, and clinical endpoint development. Regulatory requirements provide a stable underlying demand base because protein therapeutics and regulated bioanalytical studies require validated methods, traceable data, and phase-appropriate quality systems. ICH Q6B establishes the importance of characterization, identity, purity, impurities, quantity, and potency for biotechnology-derived products, while FDA M10 defines validation expectations for bioanalytical assays used in regulatory studies.
Restraints
The market is constrained by high laboratory investment, expensive analytical platforms, specialized reagents, complex sample preparation, instrument maintenance, and the limited availability of experienced mass-spectrometry, bioanalytical, and biophysical scientists. Many large pharmaceutical companies and research institutions operate internal core laboratories, reducing outsourcing demand for routine protein identification, basic immunoassays, and standardized quality tests. Price competition is particularly visible in conventional research proteomics, where broader instrument availability and increasing laboratory automation are reducing differentiation among basic service packages. Project economics can also be affected by low sample quality, matrix interference, assay redevelopment, failed validation, and repeated testing. Smaller providers may possess strong scientific capabilities but lack the quality systems, global sample logistics, data-integrity infrastructure, and regulatory inspection history required for multinational clinical or commercial programs.
Opportunities
The strongest opportunities are emerging in high-plex plasma and serum proteomics, deep data-independent acquisition workflows, targeted absolute quantification, FFPE tissue analysis, phosphoproteomics and other modification-focused services, clinical biomarker validation, and integrated multiomics interpretation. Single-cell and spatially resolved protein analysis may create additional demand as sensitivity, throughput, and reproducibility improve. Providers can also capture greater value by moving beyond sample measurement into assay development, statistical design, biomarker verification, regulatory documentation, and longitudinal clinical-program support. Regional expansion provides another growth route, particularly when laboratories combine local sample processing with globally standardized methods and centralized data analysis. Recent investments in deeper plasma-proteome workflows, high-throughput quantitative proteomics, and expanded mass-spectrometry laboratory capacity indicate that service providers are positioning for larger cohort studies and more demanding translational applications.
Challenges
Long-term challenges include limited cross-platform comparability, differences in sample preparation and data-processing pipelines, incomplete reference standards, and inconsistent reporting conventions between laboratories. Protein measurements are particularly sensitive to biological variability, preanalytical handling, matrix effects, depletion or enrichment methods, and algorithmic assumptions, making reproducibility more difficult than simple instrument throughput may suggest. High-plex biomarker studies must also address multiple-testing risk, cohort design, analytical validation, clinical relevance, and the transition from exploratory signatures to assays suitable for regulatory or diagnostic use. Laboratories operating internationally face additional requirements related to sample transport, patient consent, data privacy, biospecimen governance, and differing national quality expectations. FDA’s 2026 guidance on bioanalytical method validation for biomarkers further emphasizes the need for fit-for-purpose validation and appropriate control of analytical performance as biomarker evidence moves closer to regulatory decision-making.
VALUE CHAIN ANALYSIS
The upstream value chain consists of analytical instruments, chromatography and electrophoresis systems, antibodies and affinity reagents, sample-preparation kits, columns, reference standards, software, cloud-computing resources, laboratory automation, and highly trained scientific personnel. Instrument performance influences sensitivity and throughput, but upstream consumables, enrichment technologies, assay panels, reference materials, and data-analysis tools frequently determine reproducibility and recurring operating costs. Proprietary platforms can improve standardization and customer retention, although they may also create dependence on specific reagent and software ecosystems.
Midstream value creation occurs through study design, sample accessioning, preparation and fractionation, analytical measurement, method development and validation, quality review, bioinformatics, statistical interpretation, and final reporting. Profitability is generally higher for complex, regulated, or proprietary services than for standardized research tests because value depends on scientific expertise, documentation, risk management, and the ability to resolve difficult samples rather than instrument time alone. Downstream customers include biopharmaceutical and biotechnology companies, pharmaceutical groups, diagnostics and biomarker developers, academic institutions, CROs, and CDMOs. Long-term customer relationships are strengthened when providers can maintain methods across discovery, clinical development, CMC, commercial release, and lifecycle management.
SEGMENT INSIGHTS
By primary service deliverable, regulated biopharmaceutical analysis and characterization represents the largest value pool. Structural and physicochemical characterization, impurity testing, large-molecule pharmacokinetics, immunogenicity, potency, comparability, release, and stability testing generally command higher project values than routine research protein identification because they require validated methods, multiple orthogonal technologies, extensive documentation, and greater responsibility for data quality. Discovery proteomics remains a major volume segment, supported by academic research, target discovery, translational medicine, and biomarker programs, but conventional service packages face greater pricing pressure and competition from internal research facilities.
DOWNSTREAM MARKET OPPORTUNITIES
Biopharmaceutical and biotechnology companies represent the most important downstream customer group, particularly in antibody development, complex biologics, biosimilars, vaccines, and recombinant protein programs. Demand extends from early target discovery to clinical bioanalysis, CMC characterization, process comparability, release testing, and post-approval lifecycle management. Translational medicine and clinical research create additional opportunities for protein biomarker discovery and validation, while diagnostics developers require reproducible assays that can bridge exploratory research and clinical application. Academic customers remain important for discovery proteomics and specialized modification studies, although their purchasing is more sensitive to grant funding and internal instrument availability. The most attractive projects are those that combine technically difficult samples, large cohorts, regulatory relevance, or repeated testing across multiple development stages.
REGIONAL INSIGHTS
Fastest-Growing Region: Asia Pacific
North America remains the largest regional market because of its concentration of biopharmaceutical research, clinical development activity, specialist bioanalytical laboratories, and early adoption of high-plex proteomics platforms. The region has a broad supplier base spanning integrated laboratory groups, large CROs, regulated large-molecule bioanalysis specialists, and emerging technology companies. Europe maintains a strong position in biologics characterization, GMP analytical services, biosimilar comparability, and specialist mass-spectrometry testing, with Germany, the United Kingdom, Switzerland, Denmark, and Spain forming important service clusters.
- XX.X%CAGR*
- XXXXUS$ Million
- XXXXREGIONAL SHARE
BY TYPE,2021-2032(US $ MILLION)
Regulated Bioanalysis and Protein Biomarker Quantification
Discovery Proteomics and Proteome Profiling
Structural and Physicochemical Characterization
Others
BY APPLICATION，2021-2032(US $ MILLION）
Biopharmaceutical and Biotechnology Companies
Pharmaceutical Companies
Academic and Research Institutions
Others
China and the wider Asia-Pacific region are expanding more rapidly on the supply side. China combines internationally active CRO and CRDMO groups with domestic multiomics companies and specialized proteomics laboratories, while India is positioned around integrated drug-discovery and biologics-development services. Japan retains strengths in established industrial analytical laboratories, and South Korea and Taiwan have emerging clinical-proteomics and regional multiomics capabilities. Asian providers are also increasing overseas laboratory capacity; Novogene’s expansion of mass-spectrometry proteomics services in North America illustrates the gradual globalization of regionally developed service platforms.
COMPETITIVE LANDSCAPE ANALYSIS
The Protein Analysis Services market is moderately fragmented and organized around several distinct competitive models. Large testing groups and global CROs compete through international laboratory networks, regulatory experience, broad analytical portfolios, and the ability to support projects from discovery through commercial testing. Specialized providers compete through scientific depth in mass-spectrometry proteomics, structural characterization, immunogenicity, targeted quantification, host-cell protein analysis, or clinical biomarkers. Regional laboratories compete through customization, responsiveness, local sample handling, and lower operating costs. The core formal supplier list contains 44 confirmed groups, while the broader longlist exceeds 80 providers because many regional and mixed-business organizations possess genuine analytical capabilities but lack separately disclosed Protein Analysis Services revenue or global regulatory coverage. The ten largest groups are estimated to represent approximately 37%–43% of the narrow-scope market, indicating meaningful scale advantages without eliminating space for specialized competitors. Consolidation around Olink, SomaLogic, and Biognosys demonstrates growing strategic interest from major life-science platform companies. Future competition will increasingly focus on orthogonal method integration, automation, cross-laboratory reproducibility, regulatory credibility, turnaround time, data interpretation, and the ability to connect proteomic results with other molecular and clinical datasets.
REPORT SCOPE
The global Protein Analysis Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Protein Analysis Services market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Protein Analysis Services value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Regulated Bioanalysis and Protein Biomarker Quantification
1.2.3 Discovery Proteomics and Proteome Profiling
1.2.4 Structural and Physicochemical Characterization
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Biopharmaceutical and Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic and Research Institutions
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Protein Analysis Services Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Protein Analysis Services Market Share by Revenue, by Region (2021-2026)
2.4 Global Protein Analysis Services Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Protein Analysis Services Market Size and Prospective (2021-2032)
2.5.2 Europe Protein Analysis Services Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Protein Analysis Services Market Size and Prospective (2021-2032)
2.5.4 Latin America Protein Analysis Services Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Protein Analysis Services Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Protein Analysis Services Historical Market Size by Type (2021-2026)
3.2 Global Protein Analysis Services Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Protein Analysis Services
4 Breakdown Data by Application
4.1 Global Protein Analysis Services Historical Market Size by Application (2021-2026)
4.2 Global Protein Analysis Services Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Protein Analysis Services Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Protein Analysis Services Players by Revenue (2021-2026)
5.1.2 Global Protein Analysis Services Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Protein Analysis Services Revenue
5.4 Global Protein Analysis Services Market Concentration Analysis
5.4.1 Global Protein Analysis Services Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Protein Analysis Services Revenue in 2025
5.5 Global Key Players of Protein Analysis Services Head Offices and Areas Served
5.6 Global Key Players of Protein Analysis Services, Product and Application
5.7 Global Key Players of Protein Analysis Services, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Protein Analysis Services Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Protein Analysis Services Market Size by Type (2021-2026)
6.1.2.2 North America Protein Analysis Services Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Protein Analysis Services Market Size by Application (2021-2026)
6.1.3.2 North America Protein Analysis Services Market Share by Application (2021-2026)
6.1.4 North America Protein Analysis Services Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Protein Analysis Services Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Protein Analysis Services Market Size by Type (2021-2026)
6.2.2.2 Europe Protein Analysis Services Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Protein Analysis Services Market Size by Application (2021-2026)
6.2.3.2 Europe Protein Analysis Services Market Share by Application (2021-2026)
6.2.4 Europe Protein Analysis Services Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Protein Analysis Services Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Protein Analysis Services Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Protein Analysis Services Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Protein Analysis Services Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Protein Analysis Services Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Protein Analysis Services Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Protein Analysis Services Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Protein Analysis Services Market Size by Type (2021-2026)
6.4.2.2 Latin America Protein Analysis Services Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Protein Analysis Services Market Size by Application (2021-2026)
6.4.3.2 Latin America Protein Analysis Services Market Share by Application (2021-2026)
6.4.4 Latin America Protein Analysis Services Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Protein Analysis Services Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Protein Analysis Services Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Protein Analysis Services Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Protein Analysis Services Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Protein Analysis Services Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Protein Analysis Services Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Company Details
7.1.2 Thermo Fisher Scientific Inc. Business Overview
7.1.3 Thermo Fisher Scientific Inc. Protein Analysis Services Introduction
7.1.4 Thermo Fisher Scientific Inc. Revenue in Protein Analysis Services Business (2021-2026)
7.1.5 Thermo Fisher Scientific Inc. Recent Development
7.2 Eurofins Scientific SE
7.2.1 Eurofins Scientific SE Company Details
7.2.2 Eurofins Scientific SE Business Overview
7.2.3 Eurofins Scientific SE Protein Analysis Services Introduction
7.2.4 Eurofins Scientific SE Revenue in Protein Analysis Services Business (2021-2026)
7.2.5 Eurofins Scientific SE Recent Development
7.3 Labcorp Holdings Inc.
7.3.1 Labcorp Holdings Inc. Company Details
7.3.2 Labcorp Holdings Inc. Business Overview
7.3.3 Labcorp Holdings Inc. Protein Analysis Services Introduction
7.3.4 Labcorp Holdings Inc. Revenue in Protein Analysis Services Business (2021-2026)
7.3.5 Labcorp Holdings Inc. Recent Development
7.4 SGS SA
7.4.1 SGS SA Company Details
7.4.2 SGS SA Business Overview
7.4.3 SGS SA Protein Analysis Services Introduction
7.4.4 SGS SA Revenue in Protein Analysis Services Business (2021-2026)
7.4.5 SGS SA Recent Development
7.5 Charles River Laboratories International, Inc.
7.5.1 Charles River Laboratories International, Inc. Company Details
7.5.2 Charles River Laboratories International, Inc. Business Overview
7.5.3 Charles River Laboratories International, Inc. Protein Analysis Services Introduction
7.5.4 Charles River Laboratories International, Inc. Revenue in Protein Analysis Services Business (2021-2026)
7.5.5 Charles River Laboratories International, Inc. Recent Development
7.6 BioAgilytix Labs,LLC
7.6.1 BioAgilytix Labs,LLC Company Details
7.6.2 BioAgilytix Labs,LLC Business Overview
7.6.3 BioAgilytix Labs,LLC Protein Analysis Services Introduction
7.6.4 BioAgilytix Labs,LLC Revenue in Protein Analysis Services Business (2021-2026)
7.6.5 BioAgilytix Labs,LLC Recent Development
7.7 Merck KGaA
7.7.1 Merck KGaA Company Details
7.7.2 Merck KGaA Business Overview
7.7.3 Merck KGaA Protein Analysis Services Introduction
7.7.4 Merck KGaA Revenue in Protein Analysis Services Business (2021-2026)
7.7.5 Merck KGaA Recent Development
7.8 WuXi AppTec Co., Ltd.
7.8.1 WuXi AppTec Co., Ltd. Company Details
7.8.2 WuXi AppTec Co., Ltd. Business Overview
7.8.3 WuXi AppTec Co., Ltd. Protein Analysis Services Introduction
7.8.4 WuXi AppTec Co., Ltd. Revenue in Protein Analysis Services Business (2021-2026)
7.8.5 WuXi AppTec Co., Ltd. Recent Development
7.9 Intertek Group plc
7.9.1 Intertek Group plc Company Details
7.9.2 Intertek Group plc Business Overview
7.9.3 Intertek Group plc Protein Analysis Services Introduction
7.9.4 Intertek Group plc Revenue in Protein Analysis Services Business (2021-2026)
7.9.5 Intertek Group plc Recent Development
7.10 Frontage Laboratories,Inc.
7.10.1 Frontage Laboratories,Inc. Company Details
7.10.2 Frontage Laboratories,Inc. Business Overview
7.10.3 Frontage Laboratories,Inc. Protein Analysis Services Introduction
7.10.4 Frontage Laboratories,Inc. Revenue in Protein Analysis Services Business (2021-2026)
7.10.5 Frontage Laboratories,Inc. Recent Development
7.11 KCAS Bioanalytical Services
7.11.1 KCAS Bioanalytical Services Company Details
7.11.2 KCAS Bioanalytical Services Business Overview
7.11.3 KCAS Bioanalytical Services Protein Analysis Services Introduction
7.11.4 KCAS Bioanalytical Services Revenue in Protein Analysis Services Business (2021-2026)
7.11.5 KCAS Bioanalytical Services Recent Development
7.12 QPS HoIdings, LLC
7.12.1 QPS HoIdings, LLC Company Details
7.12.2 QPS HoIdings, LLC Business Overview
7.12.3 QPS HoIdings, LLC Protein Analysis Services Introduction
7.12.4 QPS HoIdings, LLC Revenue in Protein Analysis Services Business (2021-2026)
7.12.5 QPS HoIdings, LLC Recent Development
7.13 CellCarta Biosciences Inc.
7.13.1 CellCarta Biosciences Inc. Company Details
7.13.2 CellCarta Biosciences Inc. Business Overview
7.13.3 CellCarta Biosciences Inc. Protein Analysis Services Introduction
7.13.4 CellCarta Biosciences Inc. Revenue in Protein Analysis Services Business (2021-2026)
7.13.5 CellCarta Biosciences Inc. Recent Development
7.14 Solvias AG
7.14.1 Solvias AG Company Details
7.14.2 Solvias AG Business Overview
7.14.3 Solvias AG Protein Analysis Services Introduction
7.14.4 Solvias AG Revenue in Protein Analysis Services Business (2021-2026)
7.14.5 Solvias AG Recent Development
7.15 Bruker Corporation
7.15.1 Bruker Corporation Company Details
7.15.2 Bruker Corporation Business Overview
7.15.3 Bruker Corporation Protein Analysis Services Introduction
7.15.4 Bruker Corporation Revenue in Protein Analysis Services Business (2021-2026)
7.15.5 Bruker Corporation Recent Development
7.16 Precision for Medicine
7.16.1 Precision for Medicine Company Details
7.16.2 Precision for Medicine Business Overview
7.16.3 Precision for Medicine Protein Analysis Services Introduction
7.16.4 Precision for Medicine Revenue in Protein Analysis Services Business (2021-2026)
7.16.5 Precision for Medicine Recent Development
7.17 Illumina, Inc.
7.17.1 Illumina, Inc. Company Details
7.17.2 Illumina, Inc. Business Overview
7.17.3 Illumina, Inc. Protein Analysis Services Introduction
7.17.4 Illumina, Inc. Revenue in Protein Analysis Services Business (2021-2026)
7.17.5 Illumina, Inc. Recent Development
7.18 Pharmaron Beijing Co.,Ltd.
7.18.1 Pharmaron Beijing Co.,Ltd. Company Details
7.18.2 Pharmaron Beijing Co.,Ltd. Business Overview
7.18.3 Pharmaron Beijing Co.,Ltd. Protein Analysis Services Introduction
7.18.4 Pharmaron Beijing Co.,Ltd. Revenue in Protein Analysis Services Business (2021-2026)
7.18.5 Pharmaron Beijing Co.,Ltd. Recent Development
7.19 Evotec SE
7.19.1 Evotec SE Company Details
7.19.2 Evotec SE Business Overview
7.19.3 Evotec SE Protein Analysis Services Introduction
7.19.4 Evotec SE Revenue in Protein Analysis Services Business (2021-2026)
7.19.5 Evotec SE Recent Development
7.20 Syngene International Limited
7.20.1 Syngene International Limited Company Details
7.20.2 Syngene International Limited Business Overview
7.20.3 Syngene International Limited Protein Analysis Services Introduction
7.20.4 Syngene International Limited Revenue in Protein Analysis Services Business (2021-2026)
7.20.5 Syngene International Limited Recent Development
7.21 Novogene Co., Ltd.北京诺禾致源科技股份有限公司
7.21.1 Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Company Details
7.21.2 Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Business Overview
7.21.3 Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Protein Analysis Services Introduction
7.21.4 Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Revenue in Protein Analysis Services Business (2021-2026)
7.21.5 Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Recent Development
7.22 Aragen Life Sciences Limited
7.22.1 Aragen Life Sciences Limited Company Details
7.22.2 Aragen Life Sciences Limited Business Overview
7.22.3 Aragen Life Sciences Limited Protein Analysis Services Introduction
7.22.4 Aragen Life Sciences Limited Revenue in Protein Analysis Services Business (2021-2026)
7.22.5 Aragen Life Sciences Limited Recent Development
7.23 ProtaGene GmbH
7.23.1 ProtaGene GmbH Company Details
7.23.2 ProtaGene GmbH Business Overview
7.23.3 ProtaGene GmbH Protein Analysis Services Introduction
7.23.4 ProtaGene GmbH Revenue in Protein Analysis Services Business (2021-2026)
7.23.5 ProtaGene GmbH Recent Development
7.24 BGI Genomics Co., Ltd.
7.24.1 BGI Genomics Co., Ltd. Company Details
7.24.2 BGI Genomics Co., Ltd. Business Overview
7.24.3 BGI Genomics Co., Ltd. Protein Analysis Services Introduction
7.24.4 BGI Genomics Co., Ltd. Revenue in Protein Analysis Services Business (2021-2026)
7.24.5 BGI Genomics Co., Ltd. Recent Development
7.25 Hangzhou Jingjie Biotechnology Co., Ltd.
7.25.1 Hangzhou Jingjie Biotechnology Co., Ltd. Company Details
7.25.2 Hangzhou Jingjie Biotechnology Co., Ltd. Business Overview
7.25.3 Hangzhou Jingjie Biotechnology Co., Ltd. Protein Analysis Services Introduction
7.25.4 Hangzhou Jingjie Biotechnology Co., Ltd. Revenue in Protein Analysis Services Business (2021-2026)
7.25.5 Hangzhou Jingjie Biotechnology Co., Ltd. Recent Development
8 Protein Analysis Services Market Dynamics
8.1 Protein Analysis Services Industry Trends
8.2 Protein Analysis Services Market Drivers
8.3 Protein Analysis Services Market Challenges
8.4 Protein Analysis Services Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Protein Analysis Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Protein Analysis Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Protein Analysis Services Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Protein Analysis Services Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Protein Analysis Services Revenue Share by Region (2021-2026)
Table 6. Global Protein Analysis Services Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Protein Analysis Services Revenue Share Forecast by Region (2027-2032)
Table 8. Global Protein Analysis Services Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Protein Analysis Services Market Share by Revenue, by Type (2021-2026)
Table 10. Global Protein Analysis Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Protein Analysis Services Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Protein Analysis Services Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Protein Analysis Services Market Share by Revenue, by Application (2021-2026)
Table 15. Global Protein Analysis Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Protein Analysis Services Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Protein Analysis Services Applications
Table 18. Global Protein Analysis Services Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Protein Analysis Services Market Share by Players (2021-2026)
Table 20. Global Top Protein Analysis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Analysis Services as of 2025)
Table 21. Ranking of Global Top Protein Analysis Services Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Protein Analysis Services Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Protein Analysis Services, Headquarters and Area Served
Table 24. Global Key Players of Protein Analysis Services, Product and Application
Table 25. Global Key Players of Protein Analysis Services, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Protein Analysis Services Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Protein Analysis Services Market Share by Revenue, by Company (2021-2026)
Table 29. North America Protein Analysis Services Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Protein Analysis Services Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Protein Analysis Services Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Protein Analysis Services Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Protein Analysis Services Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Protein Analysis Services Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Protein Analysis Services Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Protein Analysis Services Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Protein Analysis Services Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Protein Analysis Services Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Protein Analysis Services Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Protein Analysis Services Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Protein Analysis Services Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Protein Analysis Services Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Protein Analysis Services Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Protein Analysis Services Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Protein Analysis Services Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Protein Analysis Services Market Size by Application (2021-2026) & (US$ Million)
Table 47. Thermo Fisher Scientific Inc. Company Details
Table 48. Thermo Fisher Scientific Inc. Business Overview
Table 49. Thermo Fisher Scientific Inc. Protein Analysis Services Product
Table 50. Thermo Fisher Scientific Inc. Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 51. Thermo Fisher Scientific Inc. Recent Development
Table 52. Eurofins Scientific SE Company Details
Table 53. Eurofins Scientific SE Business Overview
Table 54. Eurofins Scientific SE Protein Analysis Services Product
Table 55. Eurofins Scientific SE Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 56. Eurofins Scientific SE Recent Development
Table 57. Labcorp Holdings Inc. Company Details
Table 58. Labcorp Holdings Inc. Business Overview
Table 59. Labcorp Holdings Inc. Protein Analysis Services Product
Table 60. Labcorp Holdings Inc. Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 61. Labcorp Holdings Inc. Recent Development
Table 62. SGS SA Company Details
Table 63. SGS SA Business Overview
Table 64. SGS SA Protein Analysis Services Product
Table 65. SGS SA Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 66. SGS SA Recent Development
Table 67. Charles River Laboratories International, Inc. Company Details
Table 68. Charles River Laboratories International, Inc. Business Overview
Table 69. Charles River Laboratories International, Inc. Protein Analysis Services Product
Table 70. Charles River Laboratories International, Inc. Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 71. Charles River Laboratories International, Inc. Recent Development
Table 72. BioAgilytix Labs,LLC Company Details
Table 73. BioAgilytix Labs,LLC Business Overview
Table 74. BioAgilytix Labs,LLC Protein Analysis Services Product
Table 75. BioAgilytix Labs,LLC Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 76. BioAgilytix Labs,LLC Recent Development
Table 77. Merck KGaA Company Details
Table 78. Merck KGaA Business Overview
Table 79. Merck KGaA Protein Analysis Services Product
Table 80. Merck KGaA Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 81. Merck KGaA Recent Development
Table 82. WuXi AppTec Co., Ltd. Company Details
Table 83. WuXi AppTec Co., Ltd. Business Overview
Table 84. WuXi AppTec Co., Ltd. Protein Analysis Services Product
Table 85. WuXi AppTec Co., Ltd. Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 86. WuXi AppTec Co., Ltd. Recent Development
Table 87. Intertek Group plc Company Details
Table 88. Intertek Group plc Business Overview
Table 89. Intertek Group plc Protein Analysis Services Product
Table 90. Intertek Group plc Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 91. Intertek Group plc Recent Development
Table 92. Frontage Laboratories,Inc. Company Details
Table 93. Frontage Laboratories,Inc. Business Overview
Table 94. Frontage Laboratories,Inc. Protein Analysis Services Product
Table 95. Frontage Laboratories,Inc. Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 96. Frontage Laboratories,Inc. Recent Development
Table 97. KCAS Bioanalytical Services Company Details
Table 98. KCAS Bioanalytical Services Business Overview
Table 99. KCAS Bioanalytical Services Protein Analysis Services Product
Table 100. KCAS Bioanalytical Services Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 101. KCAS Bioanalytical Services Recent Development
Table 102. QPS HoIdings, LLC Company Details
Table 103. QPS HoIdings, LLC Business Overview
Table 104. QPS HoIdings, LLC Protein Analysis Services Product
Table 105. QPS HoIdings, LLC Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 106. QPS HoIdings, LLC Recent Development
Table 107. CellCarta Biosciences Inc. Company Details
Table 108. CellCarta Biosciences Inc. Business Overview
Table 109. CellCarta Biosciences Inc. Protein Analysis Services Product
Table 110. CellCarta Biosciences Inc. Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 111. CellCarta Biosciences Inc. Recent Development
Table 112. Solvias AG Company Details
Table 113. Solvias AG Business Overview
Table 114. Solvias AG Protein Analysis Services Product
Table 115. Solvias AG Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 116. Solvias AG Recent Development
Table 117. Bruker Corporation Company Details
Table 118. Bruker Corporation Business Overview
Table 119. Bruker Corporation Protein Analysis Services Product
Table 120. Bruker Corporation Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 121. Bruker Corporation Recent Development
Table 122. Precision for Medicine Company Details
Table 123. Precision for Medicine Business Overview
Table 124. Precision for Medicine Protein Analysis Services Product
Table 125. Precision for Medicine Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 126. Precision for Medicine Recent Development
Table 127. Illumina, Inc. Company Details
Table 128. Illumina, Inc. Business Overview
Table 129. Illumina, Inc. Protein Analysis Services Product
Table 130. Illumina, Inc. Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 131. Illumina, Inc. Recent Development
Table 132. Pharmaron Beijing Co.,Ltd. Company Details
Table 133. Pharmaron Beijing Co.,Ltd. Business Overview
Table 134. Pharmaron Beijing Co.,Ltd. Protein Analysis Services Product
Table 135. Pharmaron Beijing Co.,Ltd. Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 136. Pharmaron Beijing Co.,Ltd. Recent Development
Table 137. Evotec SE Company Details
Table 138. Evotec SE Business Overview
Table 139. Evotec SE Protein Analysis Services Product
Table 140. Evotec SE Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 141. Evotec SE Recent Development
Table 142. Syngene International Limited Company Details
Table 143. Syngene International Limited Business Overview
Table 144. Syngene International Limited Protein Analysis Services Product
Table 145. Syngene International Limited Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 146. Syngene International Limited Recent Development
Table 147. Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Company Details
Table 148. Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Business Overview
Table 149. Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Protein Analysis Services Product
Table 150. Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 151. Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Recent Development
Table 152. Aragen Life Sciences Limited Company Details
Table 153. Aragen Life Sciences Limited Business Overview
Table 154. Aragen Life Sciences Limited Protein Analysis Services Product
Table 155. Aragen Life Sciences Limited Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 156. Aragen Life Sciences Limited Recent Development
Table 157. ProtaGene GmbH Company Details
Table 158. ProtaGene GmbH Business Overview
Table 159. ProtaGene GmbH Protein Analysis Services Product
Table 160. ProtaGene GmbH Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 161. ProtaGene GmbH Recent Development
Table 162. BGI Genomics Co., Ltd. Company Details
Table 163. BGI Genomics Co., Ltd. Business Overview
Table 164. BGI Genomics Co., Ltd. Protein Analysis Services Product
Table 165. BGI Genomics Co., Ltd. Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 166. BGI Genomics Co., Ltd. Recent Development
Table 167. Hangzhou Jingjie Biotechnology Co., Ltd. Company Details
Table 168. Hangzhou Jingjie Biotechnology Co., Ltd. Business Overview
Table 169. Hangzhou Jingjie Biotechnology Co., Ltd. Protein Analysis Services Product
Table 170. Hangzhou Jingjie Biotechnology Co., Ltd. Revenue in Protein Analysis Services Business (2021-2026) & (US$ Million)
Table 171. Hangzhou Jingjie Biotechnology Co., Ltd. Recent Development
Table 172. Protein Analysis Services Market Trends
Table 173. Protein Analysis Services Market Drivers
Table 174. Protein Analysis Services Market Challenges
Table 175. Protein Analysis Services Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Protein Analysis Services Product Picture
Figure 2. Global Protein Analysis Services Market Share by Type: 2025 vs 2032
Figure 3. Regulated Bioanalysis and Protein Biomarker Quantification Features
Figure 4. Discovery Proteomics and Proteome Profiling Features
Figure 5. Structural and Physicochemical Characterization Features
Figure 6. Others Features
Figure 7. Global Protein Analysis Services Market Share by Application: 2025 vs 2032
Figure 8. Biopharmaceutical and Biotechnology Companies
Figure 9. Pharmaceutical Companies
Figure 10. Academic and Research Institutions
Figure 11. Others
Figure 12. Protein Analysis Services Report Years Considered
Figure 13. Global Protein Analysis Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 14. Global Protein Analysis Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Protein Analysis Services Market Share by Revenue, by Region: 2021 vs 2025
Figure 16. North America Protein Analysis Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Europe Protein Analysis Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Asia-Pacific Protein Analysis Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Latin America Protein Analysis Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Middle East & Africa Protein Analysis Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Global Protein Analysis Services Market Share by Players in 2025
Figure 22. Global Top Protein Analysis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Analysis Services as of 2025)
Figure 23. The Top 10 and 5 Players Market Share by Protein Analysis Services Revenue in 2025
Figure 24. North America Protein Analysis Services Market Share by Type (2021-2026)
Figure 25. North America Protein Analysis Services Market Share by Application (2021-2026)
Figure 26. Europe Protein Analysis Services Market Share by Type (2021-2026)
Figure 27. Europe Protein Analysis Services Market Share by Application (2021-2026)
Figure 28. Asia-Pacific Protein Analysis Services Market Share by Type (2021-2026)
Figure 29. Asia-Pacific Protein Analysis Services Market Share by Application (2021-2026)
Figure 30. Latin America Protein Analysis Services Market Share by Type (2021-2026)
Figure 31. Latin America Protein Analysis Services Market Share by Application (2021-2026)
Figure 32. Middle East & Africa Protein Analysis Services Market Share by Type (2021-2026)
Figure 33. Middle East & Africa Protein Analysis Services Market Share by Application (2021-2026)
Figure 34. Thermo Fisher Scientific Inc. Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 35. Eurofins Scientific SE Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 36. Labcorp Holdings Inc. Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 37. SGS SA Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 38. Charles River Laboratories International, Inc. Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 39. BioAgilytix Labs,LLC Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 40. Merck KGaA Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 41. WuXi AppTec Co., Ltd. Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 42. Intertek Group plc Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 43. Frontage Laboratories,Inc. Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 44. KCAS Bioanalytical Services Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 45. QPS HoIdings, LLC Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 46. CellCarta Biosciences Inc. Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 47. Solvias AG Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 48. Bruker Corporation Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 49. Precision for Medicine Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 50. Illumina, Inc. Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 51. Pharmaron Beijing Co.,Ltd. Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 52. Evotec SE Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 53. Syngene International Limited Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 54. Novogene Co., Ltd.北京诺禾致源科技股份有限公司 Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 55. Aragen Life Sciences Limited Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 56. ProtaGene GmbH Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 57. BGI Genomics Co., Ltd. Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 58. Hangzhou Jingjie Biotechnology Co., Ltd. Revenue Growth Rate in Protein Analysis Services Business (2021-2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Protein Analysis Services market size from 2026 to 2032?
The annual compound growth rate of the global Protein Analysis Services market is 8.6% 2026 to 2032.
Which companies rank high in the global Protein Analysis Services market?
What was the global market size of Protein Analysis Services in 2026?
Which region is expected to have the highest market share?
What was the global market size of Protein Analysis Services in 2032?
Related Reports
Global Protein Analysis Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Protein Analysis Services market is projected to grow from US$ 4312 million in 2025 to US$ 7638 million by 2032, at a CAGR of 8.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-30
Pages: 163
USD 4900.00
(Single User License)
Protein Analysis Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Protein Analysis Services was estimated to be worth US$ 4312 million in 2025 and is projected to reach US$ 7638 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-07-30
Pages: 144
USD 3950.00
(Single User License)
Global Protein Analysis Services Market Research Report 2026
The global Protein Analysis Services market was valued at US$ 4312 million in 2025 and is anticipated to reach US$ 7638 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-07-30
Pages: 151
USD 2900.00
(Single User License)
Global Protein Analysis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Protein Analysis Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 107
USD 4250.00
(Single User License)
Global Protein Analysis Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Protein Analysis Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 159
USD 4900.00
(Single User License)
Protein Analysis Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Protein Analysis Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-08
Pages: 132
USD 3950.00
(Single User License)
Global Protein Analysis Services Market Research Report 2025
The global market for Protein Analysis Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-08
Pages: 97
USD 2900.00
(Single User License)
Global Protein Analysis Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Protein Analysis Services market is projected to grow from US$ 4312 million in 2025 to US$ 7638 million by 2032, at a CAGR of 8.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-30
Pages: 163
USD 4900.00 (Single User License)Protein Analysis Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Protein Analysis Services was estimated to be worth US$ 4312 million in 2025 and is projected to reach US$ 7638 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-07-30
Pages: 144
USD 3950.00 (Single User License)Global Protein Analysis Services Market Research Report 2026
The global Protein Analysis Services market was valued at US$ 4312 million in 2025 and is anticipated to reach US$ 7638 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-07-30
Pages: 151
USD 2900.00 (Single User License)Global Protein Analysis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Protein Analysis Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 107
USD 4250.00 (Single User License)Global Protein Analysis Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Protein Analysis Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 159
USD 4900.00 (Single User License)Protein Analysis Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Protein Analysis Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-08
Pages: 132
USD 3950.00 (Single User License)Global Protein Analysis Services Market Research Report 2025
The global market for Protein Analysis Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-08
Pages: 97
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
KEY FINDINGS
OVERVIEW
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
VALUE CHAIN ANALYSIS
SEGMENT INSIGHTS
DOWNSTREAM MARKET OPPORTUNITIES
REGIONAL INSIGHTS
COMPETITIVE LANDSCAPE ANALYSIS
REPORT SCOPE
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now